« Previous
Next »
Titles
- Business of health insurance2
- Conduct of clinical trials of medical products during the COVID-19 public health emergency: guidance for industry, investigators, and institutional review boards2
- Coverage during a crisis: insured rate for Californians hits historic high in first year of COVID-19 pandemic2
- End-of-life issues2
- Facility quality and safety2
- Policy for temporary compounding of certain alcohol-based hand sanitizer products during the public health emergency: immediately in effect guidance for industry2
- Quality of healthcare2
- Temporary policy for preparation of certain alcohol-based hand sanitizer products during the public health emergency (COVID-19)2
- ACA offers protection as the COVID-19 pandemic erodes employer health insurance coverage1
- Access to health insurance1
- Addressing COVID-19 health disparities: opportunities for Medicaid programs1
- Administrative rulemaking1
- Alternative procedures for blood and blood components during the COVID-19 public health emergency1
- Antipsychotic medication prescribing in long-term care facilities increased in the early months of the COVID-19 pandemic1
- Are there enough experienced physicians to treat patients hospitalized with COVID?1
- Assessing England's response to Covid-19: a framework1
- Assessing vulnerability indicators and race/ethnicity1
- Black and African American adults’ perspectives on discrimination and unfair judgment in health care1
- Business practices1
- CDC found ways to use data to understand and address COVID-19 health disparities, despite challenges with existing data1